Drugs / fluticasone-vilanterol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04265105 | Dec 2021 → Jan 2023 | asthma | Royal College of Surgeons in Ireland - Medical University of Bahrain | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluticasone-vilanterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04265105 ↗ |
| Route | Inhaled | “LABA-ICS combination Inhaled Long acting Beta agonist and inhaled corticosteroid” NCT04265105 ↗ |